Crossmark Global Holdings Inc. grew its stake in Concentrix Corporation (NASDAQ:CNXC - Free Report) by 189.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,128 shares of the company's stock after buying an additional 50,482 shares during the period. Crossmark Global Holdings Inc. owned approximately 0.12% of Concentrix worth $3,559,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the stock. Orion Porfolio Solutions LLC grew its position in Concentrix by 7.5% in the third quarter. Orion Porfolio Solutions LLC now owns 5,679 shares of the company's stock worth $262,000 after acquiring an additional 398 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Concentrix by 18.4% during the third quarter. Dimensional Fund Advisors LP now owns 1,939,492 shares of the company's stock valued at $89,515,000 after purchasing an additional 301,550 shares in the last quarter. Victory Capital Management Inc. lifted its stake in Concentrix by 8.6% during the third quarter. Victory Capital Management Inc. now owns 129,429 shares of the company's stock worth $5,973,000 after purchasing an additional 10,273 shares during the last quarter. Round Hill Asset Management bought a new stake in Concentrix during the third quarter worth about $1,373,000. Finally, Huntington National Bank boosted its holdings in shares of Concentrix by 6,011.1% in the 3rd quarter. Huntington National Bank now owns 550 shares of the company's stock worth $25,000 after purchasing an additional 541 shares in the last quarter. Institutional investors own 90.34% of the company's stock.
Insiders Place Their Bets
In related news, CEO Christopher A. Caldwell acquired 1,000 shares of the stock in a transaction on Thursday, January 29th. The stock was purchased at an average price of $37.07 per share, for a total transaction of $37,070.00. Following the completion of the transaction, the chief executive officer owned 362,075 shares of the company's stock, valued at $13,422,120.25. This trade represents a 0.28% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.90% of the company's stock.
Concentrix Stock Performance
NASDAQ CNXC opened at $35.16 on Friday. The company has a 50-day simple moving average of $37.83 and a two-hundred day simple moving average of $42.06. Concentrix Corporation has a 12-month low of $29.35 and a 12-month high of $66.00. The firm has a market cap of $2.16 billion, a price-to-earnings ratio of -1.69, a PEG ratio of 0.37 and a beta of 0.50. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.67.
Concentrix (NASDAQ:CNXC - Get Free Report) last released its quarterly earnings data on Tuesday, January 13th. The company reported $2.95 EPS for the quarter, topping the consensus estimate of $2.93 by $0.02. Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.The firm had revenue of $2.55 billion for the quarter, compared to the consensus estimate of $2.54 billion. During the same quarter in the previous year, the business earned $3.26 earnings per share. The company's quarterly revenue was up 4.3% on a year-over-year basis. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. On average, equities analysts forecast that Concentrix Corporation will post 10.11 EPS for the current year.
Concentrix Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, February 10th. Shareholders of record on Friday, January 30th were paid a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 4.1%. The ex-dividend date of this dividend was Friday, January 30th. Concentrix's payout ratio is -6.91%.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on CNXC. Weiss Ratings lowered Concentrix from a "hold (c-)" rating to a "sell (d)" rating in a research report on Thursday, January 29th. Wall Street Zen upgraded Concentrix from a "hold" rating to a "buy" rating in a research report on Saturday, February 14th. Barrington Research reaffirmed an "outperform" rating and issued a $62.00 target price on shares of Concentrix in a research note on Monday, January 12th. Finally, Robert W. Baird set a $52.00 price target on shares of Concentrix in a research note on Wednesday, January 14th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $63.75.
Read Our Latest Stock Report on Concentrix
About Concentrix
(
Free Report)
Concentrix Inc NASDAQ: CNXC is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Recommended Stories
Want to see what other hedge funds are holding CNXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Corporation (NASDAQ:CNXC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Concentrix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.
While Concentrix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.